A detailed history of Centiva Capital, LP transactions in Embecta Corp. stock. As of the latest transaction made, Centiva Capital, LP holds 35,382 shares of EMBC stock, worth $442,275. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,382
Previous 20,320 74.12%
Holding current value
$442,275
Previous $384,000 22.14%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$12.35 - $19.33 $186,015 - $291,148
15,062 Added 74.12%
35,382 $469,000
Q4 2023

Feb 14, 2024

BUY
$12.87 - $19.09 $130,347 - $193,343
10,128 Added 99.37%
20,320 $384,000
Q3 2023

Nov 14, 2023

BUY
$15.0 - $22.17 $152,880 - $225,956
10,192 New
10,192 $153,000
Q1 2023

May 15, 2023

BUY
$23.07 - $32.77 $168,618 - $239,515
7,309 New
7,309 $205,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $723M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.